Wedbush Expects Weaker Earnings for Voyager Therapeutics
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Equities research analysts at Wedbush reduced their Q1 2025 earnings per share estimates for shares of Voyager Therapeutics in a research report issued on Wednesday, March 12th. Wedbush analyst Y. Zhong now anticipates that the company will earn ($0.37) per share for the quarter, down from their […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Equities research analysts at Wedbush reduced their Q1 2025 earnings per share estimates for shares of Voyager Therapeutics in a research report issued on Wednesday, March 12th. Wedbush analyst Y. Zhong now anticipates that the company will earn ($0.37) per share for the quarter, down from their […]
